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Requirement for Golgi-localized PI(4)P in fusion
of COPII vesicles with Golgi compartments
Andrés Lorente-Rodríguez and Charles Barlowe
Department of Biochemistry, Dartmouth Medical School, Hanover, NH 03755

ABSTRACT The role of specific membrane lipids in transport between endoplasmic reticulum
(ER) and Golgi compartments is poorly understood. Using cell-free assays that measure stages in ER-to-Golgi transport, we screened a variety of enzyme inhibitors, lipid-modifying enzymes, and lipid ligands to investigate requirements in yeast. The pleckstrin homology (PH)
domain of human Fapp1, which binds phosphatidylinositol-4-phosphate (PI(4)P) specifically,
was a strong and specific inhibitor of anterograde transport. Analysis of wild type and mutant
PH domain proteins in addition to recombinant versions of the Sac1p phosphoinositidephosphatase indicated that PI(4)P was required on Golgi membranes for fusion with coat
protein complex II (COPII) vesicles. PI(4)P inhibition did not prevent vesicle tethering but
significantly reduced formation of soluble n-ethylmaleimide sensitive factor adaptor protein
receptor (SNARE) complexes between vesicle and Golgi SNARE proteins. Moreover, semiintact cell membranes containing elevated levels of the ER-Golgi SNARE proteins and Sly1p
were less sensitive to PI(4)P inhibitors. Finally, in vivo analyses of a pik1 mutant strain showed
that inhibition of PI(4)P synthesis blocked anterograde transport from the ER to early Golgi
compartments. Together, the data presented here indicate that PI(4)P is required for the
SNARE-dependent fusion stage of COPII vesicles with the Golgi complex.
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INTRODUCTION
The secretory pathway is responsible for delivery of proteins and lipids from their site of synthesis at the endoplasmic reticulum (ER) to
the cell surface and the many membrane-bound compartments that
comprise the endomembrane system. Transport between these compartments is mediated by membrane vesicles and tubules that bud
from a donor membrane and selectively target to and fuse with an
acceptor membrane. This process is vital for cell growth and for maintenance of intracellular compartments as distinct biochemical environments. Many of the molecular mechanisms that underlie membrane transport are highly conserved between diverse intracellular
This article was published online ahead of print in MBoC in Press (http://www
.molbiolcell.org/cgi/doi/10.1091/mbc.E10-04-0317) on November 30, 2010.
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Abbreviations used: COPII, coat protein complex II; SNARE, soluble nethylmaleimide sensitive factor adaptor protein receptor; TRAPP, transport protein
particle; gpαf, glyco-pro-alpha-factor; DAG, diacylglycerol; PI, phosphatidylinositol; PI(4)P, phosphatidylinositol-4-phosphate; PH, pleckstrin homology; FYVE domain, zinc finger domain found in Fab1p, YOTB, Vac1p and EEA1; ENTH, Epsin
N-terminal homology; MED, marcks (myristoylated alanine-rich C-Kinase
substrate)-effector domain.
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trafficking events as well as among eukaryotic species (Bonifacino
and Glick, 2004).
After synthesis of secretory molecules at the ER, folded cargo proteins are packaged into coat protein complex II (COPII)-derived transport vesicles (Sato and Nakano, 2007). In yeast, vesicles then traffic
toward the Golgi apparatus and tether to cis-Golgi membranes in a
process that depends on Ypt1p, Uso1p, the Grh1/Bug1p complex,
and the transport protein particle (TRAPP)-I complex (Sztul and
Lupashin, 2006; Behnia et al., 2007). Vesicle fusion ensues as cognate
soluble n-ethylmaleimide sensitive factor adaptor protein receptor
(SNARE) proteins assemble into trans-SNARE complexes regulated
by the function of the SM protein Sly1p (Sudhof and Rothman, 2009)
and the SNARE dissociation chaperones Sec17p (α-SNAP) and
Sec18p (NSF) (Wickner and Schekman, 2008). Current evidence indicates that the vesicle-SNAREs involved in this process are Bet1p and
Bos1p, whereas Sed5p and Sly1p act on the Golgi compartment
(Cao and Barlowe, 2000). The R-SNARE Sec22p can function in this
fusion reaction from either vesicles or Golgi membranes (Liu and Barlowe, 2002). A complete understanding of the mechanisms underlying ER-to-Golgi transport is limited in part, however, by a lack of
knowledge of the role of membrane lipids in COPII vesicle budding,
tethering, and fusion with cis-Golgi compartments.
In addition to well-recognized structural roles in forming membrane bilayers and establishing subcellular compartments within
Molecular Biology of the Cell

eukaryotic cells, specific lipid species are known to regulate membrane dynamics (van Meer et al., 2008). Among these lipids, diacylglycerol (DAG) and the phosphoinositides (phosphorylated derivatives of phosphatidylinositol [PI]) have been implicated in diverse
cellular processes, including membrane deformation and vesicle
trafficking (Gomez-Fernandez and Corbalan-Garcia, 2007; Strahl
and Thorner, 2007; Mulet et al., 2008). Few studies, however, have
addressed the role of specific lipid species in transport between ER
and Golgi compartments.
In this study we investigated the lipid requirements for ER-toGolgi transport in the budding yeast Saccharomyces cerevisiae, focusing on the role of phosphoinositides. In vitro budding, tethering,
and fusion assays were used to screen phosphoinositide binding
domains, enzymes that modify phosphoinositides, and inhibitors of
enzymes involved in phosphoinositide metabolism. We found that
the pleckstrin homology (PH) domain of human Fapp1, which binds
specifically to PI(4)P (phosphatidylinositol-4-phosphate), was a potent and specific inhibitor of ER-to-Golgi transport. Stage-specific
assays demonstrated that PI(4)P was required at the Golgi compartment for fusion of COPII vesicles with Golgi acceptor membranes.
Moreover, reduction of PI(4)P levels significantly decreased formation of SNARE complexes between vesicle and Golgi SNARE proteins. Based on the results presented in this study, we propose that
PI(4)P is an important regulator of COPII vesicle fusion with Golgi
membranes.

RESULTS
Characterization of inhibitors of ER-to-Golgi transport
To identify specific lipid requirements for ER-to-Golgi trafficking, we
screened an array of lipid-binding domains, enzymes, and enzyme
inhibitors in cell-free assays to monitor influences on COPII vesicle
budding, vesicle tethering, or vesicle fusion with Golgi acceptor
membranes. The following lipid-binding domains were tested: the
PI(4)P-binding PH domain of human Fapp1 (Dowler
et al., 2000; Stahelin et al., 2007); a tandem repeat of the PI(3)Pbinding FYVE domainof Eea1 (Gillooly et al., 2000); the PI(4,5)P2binding ENTH domain of epsin (Rosenthal et al., 1999); the PI(4,5)
P2-binding marcks-effector domain (MED) (Wang et al., 2001); and
the DAG-binding C1b domain of protein kinase C (Johnson et al.,
2000). In addition, we tested a PI-specific phospholipase C (PI-PLC)
from Bacillus cereus (Ross et al., 1992) that converts PI into DAG and
inorganic phosphate; and the PLC inhibitor U73122, which prevents
the conversion of PI(4,5)P2 into DAG and IP3 by Plc1p, the only
known yeast PLC (Bleasdale et al., 1990; Jun et al., 2004). The concentrations of inhibitors used were in the same range as reported to
inhibit other in vitro trafficking reactions (Fratti et al., 2004; Jun et al.,
2006).
Inhibitors were initially screened for defects of overall ER-to-Golgi
transport. In this assay, washed semi-intact cell membranes containing translocated [35S]glyco-pro-alpha-factor (gpαf) were pretreated
with indicated inhibitors for 20 min at 4ºC. Reactions were then incubated for 1 h at 23ºC with purified transport factors to drive transport
of gpαf to the Golgi complex (Barlowe, 1997). Upon delivery to the
Golgi complex, gpαf receives outer-chain α1,6-mannose residues
that can be immunoprecipitated with anti-1,6-mannose-specific serum to quantify gpαf transport (Baker et al., 1988). As observed in
Figure 1A, U73122 and PH strongly inhibited ER-to-Golgi transport,
whereas C1b, PI-PLC, and FYVE moderately inhibited the reaction.
We next determined the specific stage(s) of ER-to-Golgi transport
(budding, tethering, or fusion) that were affected by each inhibitor.
To measure COPII vesicle fusion with Golgi membranes, we performed two-stage fusion reactions. In the first stage, COPII vesicles
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containing [35S]gpαf were generated from microsomes and separated from donor ER membranes by centrifugation (Cao and
Barlowe, 2000). In the second stage, washed semi-intact cell membranes pretreated with indicated inhibitors were incubated with [35S]
gpαf containing vesicles in the presence of fusion factors for 1 h at
23ºC (Cao and Barlowe, 2000). As shown in Figure 1B, U73122, PH,
and PI-PLC strongly inhibited fusion of COPII vesicles with Golgi acceptor membranes, whereas C1b and FYVE moderately inhibited
the reaction. The no acceptor membrane control (no Acpt) reflects
the level of Golgi membranes that carry over with COPII vesicles
from the microsome budding reaction.
We next determined whether the inhibitors influenced COPII
vesicle budding or vesicle tethering to Golgi membranes. For this
assay, washed semi-intact cell membranes containing [35S]gpαf were
pretreated with indicated inhibitors and then incubated for 30 min
at 23ºC with COPII proteins to drive vesicle budding (Cao et al.,
1998). Because freely diffusible vesicles can be separated from ER
and Golgi membranes by centrifugation, budding and Uso1pdependent tethering of budded vesicles to Golgi membranes can
be measured by quantifying the level of [35S]gpαf-containing diffusible vesicles in the supernatant fraction (Cao et al., 1998). As shown
in Figure 1C, U73122 was a strong inhibitor of budding, whereas
FYVE and PI-PLC were moderate inhibitors of budding. None of the
inhibitors produced a strong influence on vesicle tethering to Golgi
membranes. We observed, however, that the PH and C1b domains
caused an increase in diffusible vesicles. We interpret this increase in
diffusible vesicles to be caused primarily by a block in vesicle fusion
with Golgi membranes. To ensure that these effects did not arise
from a loss in membrane integrity, protease protection of luminal
[35S]gpαf was assessed after inhibitor treatments. As shown in Figure
1D, none of the inhibitors compromised the integrity of ER membranes at the concentrations tested, including 80 µM U73122 and
1 nM PI-PLC (unpublished data).
In summary, the tested compounds could be placed into three
general classes. The first class contains the PI(4,5)P2 binding domains, ENTH and MED, which did not have a significant effect on
ER-to-Golgi transport. The second class comprised the inhibitors
U73122, PI-PLC, and FYVE, which targeted both budding and fusion. At higher concentrations, U73122 and PI-PLC were strong inhibitors of budding and fusion, whereas FYVE produced modest
inhibition of both of these stages. The last class of inhibitors included the PH and C1b domains that acted specifically at the vesicle
fusion stage, with the PH domain acting as a more potent inhibitor.
Further study of the inhibitors U73122, PI-PLC, C1b, and FYVE will
be necessary to understand their mechanisms of inhibition. We decided to focus on the role of PI(4)P in fusion of COPII vesicles because PI(4)P is prevalent in the early secretory pathway (D’Angelo
et al., 2008) and because the PH domain acted potently and specifically at the vesicle fusion stage.

PI(4)P is required at the Golgi complex for SNARE-mediated
fusion with COPII vesicles
To determine whether the observed inhibition with the PH domain was specific for PI(4)P, we compared the wild-type PH domain
(PHWT) used in Figure 1 to a mutant (PHN,K) that does not bind
PI(4)P (Dowler et al., 2000; Blumental-Perry et al., 2006). Titration
of these binding domains in one-stage transport reactions showed
that PHWT is a dose-dependent transport inhibitor, whereas PHN,K
did not inhibit transport even at the highest concentrations tested
(Figure 2A). Furthermore, in reactions comparing one-stage transport, vesicle budding, and vesicle tethering (Figure 2B), treatment
with 5 µM PHN,K did not have detectable effects on transport,
COPII vesicle fusion requires PI(4)P
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FIGURE 1: Screen for inhibitors of ER-to-Golgi transport. (A) Washed semi-intact cells containing [35S]gpαf were
pretreated with indicated inhibitors for 20 min at 4ºC. Transport reactions were then incubated with Recon proteins
(COPII, Uso1p, and LMA1) and an ATP regeneration system at 23ºC for 1 h. The amount of Golgi-modified [35S]gpαf was
measured to determine transport efficiency. NA is the background level of transport in the absence of transport factors.
(B) Semi-intact cell acceptor membranes were pretreated with indicated inhibitors for 20 min at 4ºC and then incubated
with COPII vesicles containing [35S]gpαf in the presence of fusion factors (U/L: Uso1p and LMA1) and an ATP
regeneration system at 23ºC for 1 h. Golgi-modified [35S]gpαf was measured to determine fusion efficiency. The no Acpt
condition represents the background level of fusion in the absence of semi-intact cell acceptor membranes.
(C) Pretreated, semi-intact cells as in panel A were incubated with COPII or COPII plus Uso1p for 30 min at 23ºC. To
measure budding (black bars) or tethering (white bars), diffusible vesicles containing [35S]gpαf were separated from
semi-intact cell membranes by centrifugation. (D) Mock-budding reactions as in panel C were treated with trypsin, and
total protease protected [35S]gpαf was quantified to assess membrane integrity.

whereas 5 µM PHWT inhibited transport and caused an apparent
increase in diffusible vesicles (also observed in Figure 1C).
Because tethering was largely unaffected (Figure 2B), we conclude that this effect was caused primarily by inhibition of vesicle
fusion.
218 | A. Lorente-Rodríguez and C. Barlowe

Tethered vesicles could be prevented from fusing with Golgi
membranes if formation of trans-SNARE complexes was blocked or
if assembled trans-SNARE complexes could not catalyze membrane
fusion. To determine whether PHWT treatment prevents formation of
trans-SNARE complexes, we used an assay that measures the
Molecular Biology of the Cell

FIGURE 2: PHWT inhibits COPII vesicle fusion with Golgi membranes.
(A) Titration of PHWT (black squares) and PHN,K (white squares) in
one-stage transport experiments was performed as described in
Figure 1A. Maximum transport was equivalent to 20% overall
ER-to-Golgi transport. NA represents background level of transport in
the absence of transport factors. (B) Overall transport (black bars),
budding (gray bars) and tethering (white bars) assays were carried out
simultaneously as in Figure 1. PHWT and PHN,K were tested at 5 µM.
Arrows show background transport in the absence of transport
factors. (C) Fusion reactions were conducted as in Figure 1B and
monitored for the formation of cross-linked Bet1pI83C-Sec22pD153C
heterodimers (white bars and immunoblot) and for Golgi modification
of [35S]gpαf (black bars). Reactions were probed with antibodies
against Sec22p and Och1p (loading control). Arrow indicates position
of cross-linked linked Bet1pI83C-Sec22pD153C heterodimer.

formation of disulfide cross-links between cognate SNARE protein
pairs. In this assay, the SNARE proteins Bet1p and Sec22p contain
cysteine residues introduced into their SNARE domains in positions
Volume 22 January 15, 2011

that produce cross-linked adducts when assembled into SNARE
complexes (Flanagan and Barlowe, 2006). Briefly, we performed
two-stage fusion reactions chasing Bet1pI83C vesicles into Sec22pD153C
acceptor membranes and monitored formation of the Bet1p-Sec22p
disulfide cross-linked heterodimer in parallel with transport of [35S]
gpαf. As shown in Figure 2C, the inhibition of gpαf transport by
5 µM PHWT mirrors the inhibition of SNARE complex formation,
whereas 5 µM PHN,K did not cause detectable inhibition in this assay.
Taken together, these data indicate that the PHWT domain inhibits
fusion of COPII vesicles through specific interactions with PI(4)P and
suggests that the role of PI(4)P in fusion is upstream or simultaneous
with trans-SNARE complex assembly.
To further explore these results, we sought to biochemically deplete PI(4)P by treating membranes with recombinant Sac1, a phosphoinositide lipid phosphatase that removes the phosphate residue
from the inositol head group of PI(4)P. As a control we used the
catalytically inactive mutant Sac1C392S (Maehama et al., 2000). Surprisingly, titration of these proteins in two-stage fusion reactions
showed that the mutant Sac1C392S was a potent inhibitor of fusion
whereas the Sac1WT protein did not display an equal inhibitory effect
(Figure 3A). Moreover, in transport, budding, tethering, and twostage fusion assays, addition of 2.8 µM Sac1C392S inhibited transport,
caused COPII vesicles to accumulate, inhibited vesicle fusion, and
blocked formation of cross-linked SNARE complexes (Figure 3, B
and C). These results are similar to PHWT domain inhibition and suggested that the catalytically inactive mutant Sac1C392S acts as a PI(4)
P lipid ligand. To test this hypothesis, we performed liposome-binding assays to monitor binding of Sac1WT and Sac1C392S to PI(4)P liposomes. As shown in Figure 3D, 32% of Sac1C392S bound to PI(4)P liposomes (lane 12) compared to 2% background binding to PI
liposomes (lane 10). In contrast, 13% of Sac1WT bound to PI(4)P liposomes (compare lanes 12 and 6) with similar background binding to
PI liposomes (compare lanes 10 and 4). Together, these results indicate that the catalytically inactive Sac1C392S mutant inhibits vesicle
fusion through tight binding to membrane PI(4)P as observed for the
PHWT domain.
We were surprised that Sac1WT treatment in the 5 µM range
did not produce stronger inhibition of vesicle fusion. We considered, however, the possibility that our assay conditions may not
be optimal for Sac1 phosphatase activity to deplete PI(4)P from
semi-intact cell membranes. To promote Sac1WT activity, semiintact cell acceptor membranes were incubated with higher concentrations of Sac1WT for 30 min at 12ºC and then were diluted
into standard two-stage fusion reactions. As shown in Figure 4A,
pretreatment of acceptor membranes with increasing concentrations of Sac1WT caused a dose-dependent inhibition of vesicle fusion with concentrations greater than 25 µM near the minus acceptor control level. It should be noted that after pretreatment of
membranes with the indicated concentration of Sac1WT, membranes were diluted approximately eightfold such that maximal
final concentrations of Sac1WT in transport reactions were near
those used in Figure 3A. Therefore the inhibitory effects of Sac1WT
were likely due to catalytic activity of the enzyme and not due to
lipid ligand binding. Finally, pretreatment of acceptor membranes
with 50 µM Sac1WT also caused an accumulation of diffusible vesicles in budding reactions and strong inhibition of SNARE complex formation (Figure 4, B and C). These findings suggest that
PI(4)P present on acceptor membranes is required for efficient
SNARE complex assembly and fusion of ER-derived vesicles with
Golgi membranes.
To further support the proposal that Sac1WT inhibition was due to
the catalytic phosphatase activity of the enzyme and not due to
steric hindrance of binding to PI(4)P, Sac1WT-treated membranes
COPII vesicle fusion requires PI(4)P
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FIGURE 3: Sac1C392S inhibits COPII vesicle fusion with Golgi membranes. (A) Titration of Sac1WT (black squares) and
Sac1C392S (white squares) in two-stage fusion reactions was performed as in Figure 1B. Maximum transport was equivalent
to 32% fusion. NA shows the background level of fusion in the absence of transport factors and –Acceptor represents
fusion level in the absence of added semi-intact cell acceptor membranes. (B) Overall transport (black bars), budding
(gray bars), and tethering (white bars) assays were carried out simultaneously as in Figure 2B. Sac1WT and Sac1C392S were
tested at 2.8 µM. Arrows show background transport in the absence of transport factors. (C) Fusion reactions were
carried out as in Figure 2C and monitored for the formation of cross-linked Bet1pI83C-Sec22pD153C heterodimers (white
bars and immunoblot) and for Golgi-modified [35S]gpαf (black bars). (D) Sac1C392S is a PI(4)P lipid ligand. Sac1WT or
Sac1C392S (3 µM) were incubated with buffer (lanes 1, 2, 7, and 8), PI liposomes (lanes 3, 4, 9, and 10), or PI(4)P liposomes
(lanes 5, 6, 11, and 12) for 30 min at 30ºC. Liposomes were recovered by sedimentation, and the amount of protein in the
supernatant (S) or co-sedimenting with liposomes in the pellet (P) was determined by Coomassie blue staining of 7.5%
SDS–PAGE gels. Liposome molar composition: 50% PC, 30% PE, 10% PS, and 10% PI or PI(4)P.

were washed prior to two-stage fusion reactions to remove excess
Sac1WT. As shown in Figure 4D, this wash did not substantially reduce transport in mock treated membranes (washed vs. unwashed),
whereas the 50 µM Sac1WT pretreatment inhibited transport to near
the minus acceptor control level and was not rescued by the wash.
To show that the wash procedure was effective, immunoblot analysis
documented that ∼76% of Sac1WT was removed after washing
treated semi-intact cell acceptor membranes (Figure 4D). Moreover,
we observed that formation of the Bet1pI83C-Sec22pD153C crosslinked heterodimer was strongly inhibited by Sac1WT pretreatment
and was not rescued by the wash (Supplemental Figure S1A). In addition, direct measurement of PI(4)P levels in semi-intact cell membranes demonstrated that the Sac1WT pretreatment was effective.
After control incubations, semi-intact cell membranes contained
123 pmol PI(4)P/109 cells, whereas Sac1WT-treated membranes
220 | A. Lorente-Rodríguez and C. Barlowe

contained 78 pmol PI(4)P/109 cells (Supplemental Figure S1B). Finally, we found that N-ethylmaleimide inactivation of Sac1WT
(Maehama et al., 2000) completely prevented its inhibitory activity in
two-stage fusion reactions compared to mock treated Sac1WT (Supplemental Figure S1C). Based on the collective evidence, we conclude that pretreatment of membranes with 50 µM Sac1WT inhibits
vesicle fusion through reduction of membrane PI(4)P levels.
The fact that preincubation of acceptor membranes with Sac1WT
inhibited transport (Figure 4) suggested that PI(4)P is required on
Golgi membranes. PI(4)P, however, may also be required on COPII
vesicles for fusion with the Golgi compartment. To address this issue, we took advantage of the fact that budding is not inhibited by
treatment with 50 µM Sac1WT (Figure 4B). For this experiment, microsomes containing [35S]gpαf were treated with 50 µM Sac1WT or
buffer for 30 min at 12ºC. Treated microsomes were then used to
Molecular Biology of the Cell

FIGURE 4: Pretreatment of membranes with 50 µM Sac1WT inhibits COPII vesicle fusion with Golgi membranes. (A)
Semi-intact cell membranes pretreated with Sac1WT at 12ºC for 30 min were used in two-stage fusion reactions as
described in Figure 1B. Maximum transport is equivalent to 35% fusion. (B) Semi-intact cells pretreated with 50 µM
Sac1WT as in panel A were used in budding (black bars) and tethering (gray bars) assays as in Figure 1C. NA (white bars)
shows background budding in the absence of transport factors. (C) Sec22pD153C semi-intact cells were pretreated with
50 µM Sac1WT as in panel A, and then fusion reactions were carried out as in Figure 2C monitoring the formation of
cross-linked Bet1pI83C-Sec22pD153C heterodimers (white bars and immunoblot) and Golgi-modified [35S]gpαf fusion (black
bars). (D) Reactions were assembled as in panel A and washed twice with excess buffer prior to setting up two-stage
fusion reactions. NA shows background fusion in the absence of fusion factors, and the arrow indicates background
fusion in the absence of acceptor membranes. Aliquots of the treated membranes were immunoblotted for Sac1p using
an anti-penta-His antibody and for the Golgi membrane protein Och1p (loading control). Arrow indicates Och1p;
asterisk indicates a cross-reactivity of anti-Och1p with the Sac1WT protein.

generate COPII vesicles, and vesicles were purified by flotation on
Nycodenz density gradients (Barlowe, 1997). In two-stage fusion reactions, floated vesicles containing [35S]gpαf were chased into untreated acceptor membranes. Notably, vesicles generated in the
presence of 50 µM Sac1WT chased into acceptor Golgi membranes
as efficiently as control vesicles (Figure 5), indicating that PI(4)P is
required only at the Golgi compartment for fusion with COPII vesicles. Together these findings demonstrate that PI(4)P is required on
Golgi acceptor membranes for trans-SNARE complex assembly and
subsequent fusion with COPII vesicles.

ER-Golgi fusion factors in PI(4)P-dependent vesicle fusion
We hypothesized that PI(4)P on Golgi membranes interacted with
protein fusion factors to mediate bilayer fusion. If PI(4)P recruits a
cytosolic factor for COPII vesicle fusion with Golgi membranes, addition of crude cytosol might be expected to reverse PHWT inhibition.
Volume 22 January 15, 2011

We performed two-stage fusion reactions with increasing concentrations of cytosol in the presence of 3, 5, or 7 µM PHWT. High concentrations of cytosol, however, did not rescue PHWT inhibition of
COPII vesicle fusion with Golgi membranes (Supplemental Figure
S2) suggesting that such a PI(4)P binding fusion factor was not present in our cytosol preparation.
Next, we treated semi-intact cells with inhibitory concentrations
of PHWT, Sac1WT, or Sac1C392S and examined if known proteins involved in vesicle tethering and fusion were displaced from the
membranes. We did not detect differences in membrane association of Ypt1p, Uso1p, Sly1p, or subunits of the conserved oligomeric Golgi (COG) and TRAPP complexes. In contrast, low levels of
the SNARE disassembly chaperone Sec18p and the Grh1/Bug1
tethering complex were detected in the supernatant fraction after
treatment of semi-intact cell membranes (Supplemental Figure S3).
This observation suggested that PI(4)P levels influence membrane
COPII vesicle fusion requires PI(4)P
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FIGURE 5: PI(4)P is required at the Golgi for fusion with COPII
vesicles. Microsomes containing [35S]gpαf were treated with 50 µM
Sac1WT or buffer (mock) at 12ºC for 30 min. Treated microsomes were
then used to generate COPII vesicles, and vesicles were purified by
flotation on Nycodenz density gradients. Isolated vesicles were then
incubated in two-stage fusion reactions with untreated semi-intact cell
acceptor membranes as in Figure 1B.

association of specific fusion factors. We note, however, that addition of a crude cytosol, which contained Grh1p, Bug1p, and Sec18
(Supplemental Figure S2), or the addition of purified Sec18p
(see Figure 7 later in the paper) did not compete with PHWT for
inhibition of transport.
To further explore the hypothesis that a PI(4)P binding factor promotes COPII vesicle fusion, we took a candidate-based approach to
screen viable yeast deletion strains lacking proteins shown to have
affinity for PI(4)P (Supplemental Table S1). Previous reports have
characterized PI(4)P binding proteins in yeast based on an analysis
of PH domain–containing proteins (Yu et al., 2004) and on lipidbinding assays using proteome chips (Zhu et al., 2001). We prepared semi-intact cell acceptor membranes from more than 20 different candidate strains, including the combined osh1Δ osh2Δ
osh3Δ deletion mutant (Beh et al., 2001) to account for potential
redundancy. In two-stage fusion reactions, all of the acceptor membranes tested displayed wild-type levels of fusion with the exception of gcs1Δ strain, which was reduced to 47% of the wild-type level
(Supplemental Table S1). GCS1 encodes an Arf-GAP known to act in
COPI-dependent Golgi to ER retrograde transport but is also reported to regulate assembly of ER-Golgi SNARE protein complexes
(Poon et al., 1999; Schindler and Spang, 2007). Further experimentation will be required to determine whether the gcs1Δ mutation
produces a direct or indirect effect on fusion of COPII vesicles with
Golgi membranes. We note, however, that addition of crude cytosol
to transport reactions, which contained Gcs1p, did not reverse PHWT
inhibition of transport (Supplemental Figure S2).
We also considered the possibility that essential membranebound proteins could be involved in PI(4)P-dependent vesicle fusion
at Golgi membranes. The ER-Golgi SNARE proteins could interact
with PI(4)P as suggested by studies of other SNARE-dependent membrane fusion events (James et al., 2008; Lam et al., 2008; Mendonsa
and Engebrecht, 2009; Mima and Wickner, 2009; Murray and Tamm,
2009). To investigate this hypothesis we characterized PI(4)P-dependent vesicle fusion in membranes overexpressing Sly1p and the four
ER-Golgi SNARE proteins.

Overexpression of SNARE proteins and Sly1p alleviates the
PI(4)P requirement in fusion
Because inhibition of PI(4)P function in ER-to-Golgi transport prevented formation of SNARE complexes but did not have a significant effect on vesicle tethering, we hypothesized that the role of
222 | A. Lorente-Rodríguez and C. Barlowe

PI(4)P in fusion might be required downstream of tethering but before or simultaneous with SNARE protein function. Thus, we reasoned that overexpression of the fusion machinery (all four ER-Golgi
anterograde SNAREs and Sly1p) might yield acceptor membranes
that are resistant or less sensitive to the PHWT inhibitor. We constructed the overproducer strains by transforming wild-type yeast
with empty vectors (control) or with 2µ plasmids containing the
BET1, BOS1, SEC22, SED5, and/or SLY1 under control of their endogenous promoters. Different combinations of SNARE overexpressing acceptor membranes were tested in two-stage fusion reactions. Overexpression of certain combinations produced modest
levels of resistance to 3 or 5 µM PHWT (unpublished data). Overexpression of all four anterograde ER-Golgi SNAREs and SLY1, however, provided a higher level of resistance to PHWT compared to the
partial overexpressor strains. Therefore we further characterized this
overexpressor strain.
To determine fold overexpression and test whether overexpression influenced other ER-to-Golgi transport factors, we prepared
semi-intact cell membranes from the strain overexpressing BET1,
BOS1, SEC22, SED5, and SLY1 (from here on referred to as the overexpressor) for comparison with control strains. Experiments to assess the distribution of proteins contained in total, soluble, and
membrane pellet fractions monitored the overexpressed proteins
and a variety of other ER- and Golgi-localized markers (Figure 6A).
We observed that Bet1p, Bos1p, Sec22p, Sed5p, and Sly1p were
overexpressed three- to ninefold (compare total lanes), whereas the
expression level and fractionation behavior of other marker proteins
was not detectably altered.
Bet1p, Bos1p, Sec22p, and Sed5p are known to cycle between
the ER and Golgi compartments and are efficiently packaged into
COPII vesicles (Cao and Barlowe, 2000); therefore, we expected increased levels of these SNARE proteins in COPII vesicles from

FIGURE 6: Characterization of membranes that overexpress
anterograde ER-Golgi SNARE proteins and Sly1p. (A) Semi-intact cells
from the overexpressor strain containing 2µ-BET1, 2µ-BOS1,
2µ-SEC22, 2µ-SED5, and 2µ-SLY1 (CBY3061) and the wild-type strain
(CBY3062) were fractionated into soluble (S100) and pellet (P100)
fractions for immunoblot analysis. (B) Budding reactions in which
CBY3061 and CBY3062 microsomes were incubated in the absence (–)
or presence (+) of COPII proteins for 30 min at 23ºC. Immunoblots
compare indicated proteins in budded vesicle fractions with one-tenth
of total (T) budding reactions. Longer exposures (dark) are included
for the Sec22p and Bet1p immunoblots.
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overexpressor membranes. Relative COPII packaging efficiencies
were measured in budding assays using microsomes from the wild
type and overexpressor strains. As shown in Figure 6B, the ER-Golgi
SNARE proteins were 8- to 15-fold more abundant in overexpressor
microsomes compared to wild type (total lanes). In budding assays,
we observed increased levels of Bet1p (1.5-fold), Bos1p (2-fold), and
Sec22p (5-fold) in COPII vesicles. Sed5p and Sly1p, however, were
not increased in vesicles, which may be explained by the steadystate localization of Sed5p to cis-Golgi membranes (Wooding and
Pelham, 1998). As a negative control, the ER resident Sec63p was
not packaged into COPII vesicles. The packaging of known COPII
vesicle proteins, such as Erv25p and Erv46p, was not changed.
Taken together, these data show that COPII vesicles from overexpressor membranes contain more Bet1p, Bos1p, and Sec22p than
wild-type membranes and that the distribution of other proteins involved in ER-to-Golgi transport was not sensitive to overexpression
of Sly1p and the anterograde ER-Golgi SNARE proteins.
We next investigated how this overexpression condition influenced vesicle fusion. Addition of Sec18p to one-stage and twostage fusion reactions has a minor effect on fusion rates, probably
because of the abundant levels of Sec18p found in association with
semi-intact cell membranes (Barlowe, 1997). We reasoned, however,
that overexpressor membranes might require additional Sec18p to
prime SNARE proteins for maximal fusion. Titration of recombinant
Sec18p in one-stage transport reactions using overexpressor membranes indicated that ∼4 µM produced maximal stimulation (unpublished data), similar to previous titrations of Sec18p using washed
Golgi membrane preparations (Barlowe, 1997). As shown in
Figure 7A, we observed that transport with overexpressor and control membranes was indistinguishable in the absence of Sec18p.
Addition of 4 µM Sec18p, however, stimulated transport ∼1.6-fold in
overexpressor membranes, whereas wild-type membranes were not
stimulated by Sec18p addition. Moreover, there was a decrease in
sensitivity to inhibition by 3 µM PHWT in the overexpressor membranes compared to control, which was further enhanced by addition of 4 µM Sec18p. Interestingly, the level of transport in the overexpressor membranes in the presence of Sec18p and PHWT was
similar to that of wild-type membranes in the absence of PHWT
(Figure 7A).
Sec18p likely stimulates transport at the vesicle fusion stage by
resolving abundant cis-SNARE complexes in overexpressor membranes, although there could be an influence on vesicle budding. To
test this possibility, we performed [35S]gpαf budding reactions from
wild type and overexpressor microsomes and found that there were
no significant differences in gpαf budding between the wild type
and overexpressor membranes with or without added Sec18p
(Figure 7B). These data indicate that Sec18p treatment potentiates
fusion of COPII vesicles and that transport in the presence of 4 µM
Sec18p with the overexpressor membranes is significantly less sensitive to the PHWT inhibitor.
Finally, acceptor membranes from the overexpressor strain were
used in two-stage fusion experiments using wild-type vesicles in the
presence or absence of recombinant Sec18p and increasing concentrations of PHWT. We observed that PHWT produced the expected
dose-dependent inhibition of transport when chasing wild-type
vesicles into wild-type membranes (Figure 7C, compare to Figure
2A) and that addition of Sec18p to this reaction displayed partial
rescue of the PHWT inhibition. Interestingly, transport was significantly less sensitive to increasing concentrations of PHWT inhibitor
when wild-type vesicles were chased into overexpressor membranes, and the addition of Sec18p significantly enhanced this rescue (Figure 7C and Supplemental Figure S4). Together, these data
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FIGURE 7: Overexpression of anterograde ER-Golgi SNAREs and
Sly1p partially rescues PHWT inhibition. (A) Transport in wild-type
(CBY3062) and overexpressor (CBY3061) semi-intact cells incubated
for 20 min at 4ºC with 3 µM PHWT and/or 4 µM Sec18p followed by
transport for 1 h at 23ºC. (B) Microsomes treated as in panel A were
mock treated (NA) or incubated with COPII proteins for 30 min at
23ºC to monitor budding. (C) Indicated semi-intact cell acceptor
membranes were pretreated with PHWT and/or 4 µM Sec18p for
20 min at 4ºC, then were incubated with COPII vesicles containing
[35S]gpαf in the presence of fusion factors for 1 h at 23ºC. The –Acpt
condition indicates background fusion in the absence of added
acceptor membranes. The data in panel C are plotted relative to
control transport levels in Supplemental Figure S4.

indicate that increasing the amount of anterograde ER-Golgi SNARE
proteins and Sly1p does not bypass but alleviates the requirement
for PI(4)P on Golgi membranes for vesicle fusion.
COPII vesicle fusion requires PI(4)P
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PI(4)P is required for ER-to-Golgi transport in vivo
A central role for PI(4)P in Golgi secretory function was first reported
in sec14 and pik1 mutants, which show reduced levels of cellular
PI(4)P and kinetic defects in Golgi transport at restrictive temperatures (Hama et al., 1999; Walch-Solimena and Novick, 1999; Audhya
et al., 2000). At steady state, Pik1p localizes to trans-Golgi and inner-nuclear compartments (Walch-Solimena and Novick, 1999;
Strahl et al., 2005). In both yeast and mammalian cells, Pik1p-generated Golgi PI(4)P is required to recruit clathrin adaptor proteins for
export from trans-Golgi membranes (D’Angelo et al., 2008; Clague
et al., 2009). Therefore a reduction in PI(4)P at Golgi membranes
caused by shifting pik1 mutants to the restrictive temperature
strongly inhibits anterograde transport from the Golgi compartment. It should be noted, however, that ER-to-Golgi transport in
these experiments was also kinetically delayed (Walch-Solimena
and Novick, 1999; Audhya et al., 2000).
On the basis of these reports and our in vitro data, we hypothesized that a pool of Golgi-localized PI(4)P is required for proper
trafficking into cis-Golgi compartments as well as out of the transGolgi complex. We also considered the possibility that a PI(4)P
gradient across the Golgi complex, with highest requirements at

trans-compartments, could cause inhibition of trans-Golgi export
first, followed by inhibition of ER-to-Golgi transport. To test this
hypothesis, we modified the protocol from Audhya and colleagues
to increase the amount of time mutant cells were incubated at the
restrictive temperature prior to initiating the pulse-chase experiment
(Audhya et al., 2000). As shown in Figure 8A, pik1–83 cells displayed
a dramatic block in maturation of the ER-form (p1) of carboxypeptidase Y (CPY) into the Golgi-form (p2) compared to wild-type cells,
indicative of a block in ER-to-Golgi transport. Taken together, these
results suggest that traffic out of the trans-Golgi complex is more
sensitive to PI(4)P depletion (Audhya et al., 2000) but that continued
deficiency in Pik1p activity blocks transport to the cis-Golgi compartment. In addition, it is also possible that PI(4)P could be required for additional transport steps within the Golgi complex.
Given the highly dynamic nature of the Golgi complex, we investigated an alternative possibility that loss of Pik1p caused a general
disassembly of Golgi structures. To address this possibility, we compared growth rates and Golgi morphologies in pik1–83 and wildtype cells after shift to the restrictive temperature. As shown in
Figure 8B, both strains displayed similar growth kinetics and remained metabolically active up to 1 h after the shift to 37°C. At the

FIGURE 8: Depletion of PI(4)P in vivo causes a block in ER-to-Golgi transport and influences Golgi morphology. (A)
Wild-type (SEY6210) and pik1–83 (AAY104) strains grown to a mid-log stage at 26ºC were shifted to 37ºC for 45 min,
pulsed for 7 min at 37ºC, and chased at 37ºC for the indicated times. The ER (p1), Golgi (p2), and vacuolar (m; mature)
forms of CPY are indicated. Note the block in maturation of p1 CPY in the mutant. (B–E) Wild-type (CBY2970, CBY2973,
CBY2974) and pik1–83 (CBY2980, CBY2983, and CBY2984) cells expressing Sec63p-GFP (C), Sec21p-GFP (D), or
Sec7p-GFP (E) were grown on YPD at 26ºC to 0.4 OD600/ml and shifted to 37ºC. (B) Cultures were analyzed for growth
over time by absorbance. (C-E) pik1–83 cells retain ER (C), cis-Golgi (D), and late-Golgi (E) structures. Scale bars: 5 µm. A
quantitative analysis of ER and Golgi morphologies observed in a population of cells at the 1-h time point is provided in
Supplemental Figure S5.
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2- and 3-h time points, however, the pik1–83 cells ceased growth.
We note that our chase was initiated at a time point that roughly
corresponded to the last chase time point of the published data
(Audhya et al., 2000) and that the 5- and 15-min time points in our
pulse-chase experiment corresponded to a total time at the restrictive temperature of 57 and 67 min, respectively, suggesting that the
observed block in ER-to-Golgi transport was not caused by a general metabolic defect.
To inspect organelle morphologies after the temperature shift,
we monitored ER, cis-Golgi, and trans-Golgi markers by fluorescence microscopy of Sec63p-GFP, Sec21p-GFP, and Sec7p-GFP,
respectively. As shown in Figure 8, C–E, ER and Golgi structures
were visible in mutant cells after 1 h and even 2 h at the restrictive
temperature. Based on the time frame of our pulse-chase experiment, we quantified morphologies 1 h after shift to the restrictive
temperature. ER morphology was not significantly altered at the 1-h
time point as observed by a ∼15% reduction in the number of cells
with wild-type structures (Figure 8C and Supplemental Figure S5C).
In addition, we did not detect noticeable alterations in ER exit site
morphology when Sec13p-GFP was observed in pik1–83 cells
compared to wild type (unpublished data). Both cis- and trans-Golgi
membrane markers, however, showed an increase in the number of
smaller Golgi puncta accompanied by larger ring-like structures that
presumably correspond to Berkeley bodies also observed in arf1Δ,
gea1Δ, sec7–1, and pik1–101 mutants (Gaynor et al., 1998; Peyroche
et al., 2001; Bruinsma et al., 2004; Karhinen and Makarow, 2004;
Demmel et al., 2008). Quantification of Golgi morphologies demonstrated acute defects at trans-Golgi compartments with a ∼64% reduction the number of cells with wild-type trans-Golgi structures
and moderate defects at cis-Golgi compartments with a ∼36%
reduction in the number of cells with wild-type cis-Golgi structures
(Figure 8, D and E, and Supplemental Figure S5C). These observations indicate that Pik1p deficiency does not cause a general loss
of Golgi membranes and is consistent with a block in both export
from trans-Golgi compartments and transport into cis-Golgi
compartments.

DISCUSSION
The study of anterograde ER-to-Golgi traffic has yielded a comprehensive list of proteins and mechanisms involved in vesicle budding,
cargo sorting, and fusion of COPII vesicles with the Golgi complex.
We know little, however, about the role that specific lipids play in
these processes. To advance our understanding, we performed the
first screen for phosphoinositide requirements in anterograde ERto-Golgi transport in yeast using a number of lipid-binding domains,
enzymes, and enzyme inhibitors in cell-free budding, tethering, and
fusion assays. We classified the effects of these compounds into
distinct categories. The first group comprised the PI(4,5)P2 binding
domains (ENTH and MED), which did not have a significant effect on
ER-to-Golgi transport. A second group comprised inhibitors that
targeted both budding and fusion and included the PLC inhibitor
U73122, a PI-specific PLC, and the PI(3)P binding domain (FYVE). A
third group comprised inhibitors that specifically targeted fusion of
COPII vesicles and included the PI(4)P and DAG binding domains
(PH and C1b, respectively).
PI(4)P is the most abundant cellular phosphoinositide (Lemmon,
2008) and is prevalent at the Golgi complex with additional pools
detected at the plasma and nuclear membranes (D’Angelo et al.,
2008). In both yeast and mammalian cells, the Golgi pool of PI(4)P is
required for Golgi secretory function (D’Angelo et al., 2008), and
was recently shown to be required for retention of cis-, medial-, and
trans-Golgi glycosyltransferases in yeast (Tu et al., 2008; Wood
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et al., 2009). Golgi levels of PI(4)P are thought to be regulated by
multiple activities, including the PI-transfer protein Sec14p (Mousley
et al., 2007), the trans-Golgi localized PI 4-kinase Pik1p, and the
ER-localized phosphoinositide-phosphatase Sac1p (Mayinger,
2009). Using a PI(4)P-specific PH domain lipid ligand and a recombinant Sac1p-phosphatase to reduce the levels of PI(4)P in vitro, we
observed that PI(4)P was not involved in budding or tethering of
COPII vesicles, but was required on Golgi acceptor membranes for
fusion with COPII vesicles. More specifically, we found that inhibition of PI(4)P function reduced formation of the SNARE complexes
that catalyze fusion of vesicles with Golgi membranes.
In vitro COPII vesicle budding from synthetic liposomes was
shown to require low concentrations of PI(4)P and PI(4,5)P2 to
achieve efficient binding of Sec23/Sec24 and to support vesicle
budding (Matsuoka et al., 1998). Our data indicate that neither
phosphoinositide is required for COPII vesicle budding on ER
membranes, although other acidic phospholipids on the ER surface could satisfy this requirement. Alternatively, recruitment of
Sec23/Sec24 by protein cargo molecules on the surface of ER
membranes may be sufficient to assemble COPII coats for vesicle
budding, as observed on synthetic proteoliposomes (Sato and
Nakano, 2005).
In mammalian cells, evidence suggests that PI(4)P is required
for remodeling ER exit sites and regulating COPII vesicle budding
(Blumental-Perry et al., 2006). In vitro, we did not detect a requirement for PI(4)P in COPII budding from yeast ER, and in vivo pik1–83
yeast cells shifted to a restrictive temperature did not accumulate
ER membranes or cause disassembly of Golgi compartments as
would be expected if COPII budding were inhibited (Wooding and
Pelham, 1998; Prinz et al., 2000; Heidtman et al., 2003; Kamena
et al., 2008; Lorente-Rodriguez et al., 2009). This contrast may be
explained by differences in the structural organization of ER export
sites between yeast and mammalian cells. We speculate, however,
that PI(4)P functions in both yeast and mammalian cells for fusion
of COPII vesicles with Golgi membranes based on the evidence
that, in both species, Golgi PI(4)P is required for Golgi secretory
function (D’Angelo et al., 2008) and that Golgi PI(4)P levels are
tightly regulated by PI 4-kinases and PI(4)P 4-phosphatases in response to growth conditions (Mayinger, 2009). In addition, PI(4)P
was recently observed to significantly colocalize with cis-Golgi
tethering factors in mammalian cells (Hammond et al., 2009).
Further experimentation will be needed, however, to demonstrate
whether PI(4)P mediates fusion at early Golgi compartments in
mammalian cells.
On the basis of the collective findings, we hypothesize that a
trafficking-dependent gradient of PI(4)P is established across the
Golgi complex with its highest levels at the trans-Golgi and lowest
levels at the cis-Golgi compartments. This PI(4)P gradient would be
necessary for transport into and out of the Golgi complex. Because
Pik1p and Sac1p have been implicated in regulating Golgi PI(4)P
levels in yeast and mammalian cells (Mayinger, 2009), we propose
that this gradient is regulated by Pik1p and Sac1p activities. This
hypothesis is supported by our observation that pik1–83 cells
shifted to a restrictive temperature for 1 h displayed morphological
defects in trans-Golgi structures, accompanied by moderate defects in cis-Golgi structures. In this framework, inactivation of Pik1p
would initially inhibit anterograde transport from trans-Golgi membranes (Walch-Solimena and Novick, 1999; Audhya et al., 2000). As
retrograde transport continues, depletion of PI(4)P from cis-Golgi
compartments would ultimately inhibit fusion of ER-derived vesicles with Golgi membranes. This proposal is consistent with our
analysis of pik1–83 semi-intact cell membranes in vitro, which did
COPII vesicle fusion requires PI(4)P
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not display thermosensitive defects in cell-free transport assays
(Supplemental Figure S6). By increasing the time of pik1–83 inactivation compared to published reports (Audhya et al., 2000), we
detected a strong block in ER-to-Golgi transport. It is interesting to
note that mutations that mislocalize Sac1p to the Golgi also produce kinetic delays in ER-to-Golgi transport in addition to anterograde transport defects from the Golgi (Schorr et al., 2001; Konrad
et al., 2002). Taken together, these data are consistent with an in
vivo requirement for PI(4)P in fusion of COPII vesicles with the Golgi
apparatus.
What is the molecular function of PI(4)P in fusion? We observed
that overexpression of the fusion factors BET1, BOS1, SEC22, SED5,
and SLY1 partially rescued PHWT-mediated inhibition of COPII vesicle fusion with Golgi membranes. This result indicates that PI(4)P
may act concomitantly with SNARE protein function. We hypothesize that cis-Golgi localized PI(4)P interacts directly with SNARE proteins and increases their local concentrations at specific fusion sites
to promote COPII vesicle fusion with the Golgi. There is precedent
for this type of association. SNARE proteins are known to associate
with membranes through phosphoinositide-binding domains, as is
the case for the soluble SNARE Vam7p, which is recruited to the
vacuolar membrane by PI(3)P (Cheever et al., 2001; Fratti et al.,
2004). Alternatively, SNARE proteins often contain polybasic juxtamembrane regions, which directly interact with negatively charged
lipids (i.e., phosphatidic acid and phosphoinositides), as is the case
for yeast and mammalian exocytic SNARE proteins. Moreover, these
SNARE–lipid interactions are required for secretion and viability (Van
Komen et al., 2005; Vicogne et al., 2006; James et al., 2008; Lam
et al., 2008; Mendonsa and Engebrecht, 2009; Murray and Tamm,
2009; Williams et al., 2009). Similar interactions between Golgilocalized PI(4)P and specific motifs in ER-Golgi SNARE proteins may
be required to catalyze efficient fusion of ER-derived vesicles with
Golgi membranes.
In summary, this study establishes a new requirement for PI(4)P in
SNARE-dependent fusion of COPII vesicles with Golgi membranes.
Given the level of conservation in ER-to-Golgi transport machinery,
PI(4)P function in COPII vesicle fusion with the Golgi complex is
likely to be conserved and therefore constitutes an additional mech-

Strain

anism to control transport through the early secretory pathway. A
refined cell-free fusion assay and facile genetic approaches should
allow us to determine if specific ER-to-Golgi SNARE proteins or potentially other fusion factors are recruited by PI(4)P to membrane
fusion sites.

MATERIALS AND METHODS
Yeast strains and media
Yeast strains used in this study are listed in Table 1. Unless noted
otherwise, cultures were grown at 26ºC (for temperature-sensitive
mutant stains) or 30ºC in rich medium (YPD: 1% yeast extract, 2%
peptone, 2% dextrose) or in minimal medium (YMD: 0.7% yeast nitrogen base without amino acids, 2% dextrose, and appropriate
amino acid supplements). Standard yeast (Sherman, 1991) and cloning protocols (Ausubel et al., 1987) were used. Yeast cells were
transformed by the lithium acetate method (Elble, 1992).
Plasmids pRS426-BOS1 and YEp511-BET1(LEU2) have been described (Dascher et al., 1991; Duden et al., 1994). Plasmid pRS423SEC22 was constructed by subcloning a ∼1.5-kb BamHI-EcoRV fragment of YEp511-SEC22 (Dascher et al., 1991) into pRS423
(Christianson et al., 1992). Plasmids pRS424-SED5 and pRS327-SLY1
were generated by amplifying BY4742 genomic DNA including
300–500 bp upstream and downstream sequences and cloning into
pRS424 (Christianson et al., 1992) or pRS327 (Eriksson et al., 2004).
Plasmids generated in this study were confirmed by sequencing.
FY834 was transformed with appropriate empty vectors or with the
BET1, BOS1, SEC22, SED5, and SLY1 2µ vectors to generate
CBY3062 and CBY3061, respectively. Overexpression was confirmed by immunoblot (Figure 6).
Wild-type (SEY6210) and pik1–83 (AAY104) strains were transformed with pJK59 [CEN SEC63-GFP URA3] (Prinz et al., 2000), or a
chromosomal GFPx3 tag was introduced into the SEC21 and SEC7
loci as described (Rossanese et al., 2001) to generate CBY2970,
CBY2973, CBY2974, CBY2980, CBY2983, and CBY2984.

Reagents
Purified lipid-binding domains GST-ENTH (Rosenthal et al., 1999),
C1b (C-terminal glutathione S-transferase [GST] cleaved) (Johnson

Genotype

Source

AAY104

SEY6210; pik1Δ::HIS3 [pRS314-pik1–83]

Audhya et al., 2000

BY4742

MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0

Brachmann et al., 1998

CBY1584

BY4742; sec22Δ::KANR [pRS313-SEC22(D153C)]

Flanagan and Barlowe, 2006

CBY1676

BY4742; bet1Δ::KAN [pRS315-BET1(I83C)]

Flanagan and Barlowe, 2006

CBY2970

SEY6210; [pSEC63-GFP, URA3, CEN (pJK59)]

This study

CBY2973

SEY6210; SEC21-GFPx3

This study

CBY2974

SEY6210; SEC7-GFPx3

This study

CBY2980

AAY104; [pSEC63-GFP, URA3, CEN (pJK59)]

This study

CBY2983

AAY104; SEC21-GFPx3

This study

CBY2984

AAY104; SEC7-GFPx3

This study

CBY 3061

FY834; [pRS423-SEC22, HIS3] [pRS424-SED5, TRP1] [YEp511-BET1, LEU2]
[pRS426-BOS1, URA3] [pRS327-SLY1, LYS2]

This study

CBY3062

FY834; [pRS423] [pRS424] [pRS425] [pRS426] [pRS327]

This study

FY834

MATα his3Δ200 ura3–52 leu2Δ1 lys2Δ202 trp1Δ63

Winston et al., 1995

SEY6210

MATα leu2–3,112 ura3–52 his3-Δ200 trp1-Δ901 lys2–801 suc2-Δ9

Robinson et al., 1988

R

TABLE 1: Strains used in the study.
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et al., 2000), GST-FYVE2 (Gillooly et al., 2000), MED (Wang et al.,
2001), HIS6-Sec18p (Thorngren et al., 2004), and U73122 were the
gifts of Bill Wickner (Dartmouth).
Plasmids expressing the PH domain of human Fapp1 (PI(4)P
adaptor protein-1; residues 1–99) as a wild-type construct (PHWT)
(Dowler et al., 2000) or as the W15N, R18K mutant (PHN,K) (Weixel
et al., 2008) cloned as N-terminal fusions with maltose binding
protein (MBP) were the gifts of Christopher Stroupe (Dartmouth).
MBP fusion proteins were purified according to New England
Biolabs (Ipswich, MA) recommendations and dialyzed into buffer
88 (20 mM HEPES-KOH pH 7.0, 250 mM sorbitol, 150 mM KOAc,
5 mM MgOAc) without sorbitol. Plasmids expressing the
soluble domain of Sac1p (residues 1–507) as a wild-type HIS6-Sac1
construct (Sac1WT) or the catalytically inactive C392S mutant
(Sac1C392S) were the gifts of Gregory Taylor (University of Nebraska
Medical Center). His6 fusion proteins were purified according
to QIAGEN (Valencia, CA) recommendations and dialyzed
into buffer 88 without sorbitol containing 0.5 mM dithiothreitol
(DTT). The activity of these Sac1 recombinant proteins was confirmed using synthetic liposomes as described (Maehama et al.,
2000) and using semi-intact cell membranes (Supplemental
Figure S1B).
PI-PLC was purchased from Invitrogen (Carlsbad, CA). Nycodenz,
deuterium oxide (D2O), and methylene blue were purchased from
Sigma Chemical (St. Louis, MO). Coomassie brilliant blue R-250 was
purchased from Bio-Rad (Hercules, CA). All membrane transport inhibitors were diluted with buffer 88 to the appropriate concentration
and screened for inhibition of in vitro transport at the indicated
concentrations.

Lipids and liposome-binding assay
POPC, POPE, POPS, soy PI (Avanti Polar Lipids, Alabaster, AL),
Rhodamine-labeled DHPE (Invitrogen, Carlsbad, CA) and diC16
D-myo-PI(4)P (Echelon Biosciences, Salt Lake City, UT), were purchased from the indicated sources. Liposomes were prepared as
described (Patki et al., 1997) with minor modifications. Lipids were
mixed in glass tubes at the following molar ratios of 50% POPC,
29.75% POPE, 0.25% Rhodamine labeled DHPE, 10% POPS, and
10% soy PI or diC16 D-myo-PI(4)P, then dried to a thin film under
a stream of nitrogen gas and resuspended to a final concentration of 2 mg total lipid / ml Sac1 phosphatase buffer (Maehama
et al., 2000): 100 mM NaOAc, 50 mM Bis-Tris, 50 mM Tris-HCl,
pH 6.0, 2 mM DTT. Resuspended lipids were sonicated for 5 min
at 30ºC, separated into 50-µl aliquots, flash-frozen, and stored
at –70ºC.
Liposome-binding assays were as described (Loyet et al., 1998)
with minor modifications. Sac1WT and Sac1C392S proteins were precleared by centrifugation at 270,000 × g for 10 min. Binding reactions (70 µl) containing 3 µM precleared Sac1WT or Sac1C392S protein
in Sac1 phosphatase buffer with or without 50 µl of PI or PI(4)P liposomes were incubated for 30 min at 30ºC. Bovine serum albumin
(BSA) was added to 1 mg/ml to minimize nonspecific binding. Liposomes were recovered by sedimentation at 270,000 × g for 10 min,
and an aliquot of the supernatant was collected. Pellets were washed
with excess Sac1 phosphatase buffer containing BSA at 1 mg/ml
and resuspended to the initial volume with wash buffer. Equivalent
volumes were resolved on 7.5% SDS–PAGE gels and stained with
0.05% Coomassie brilliant blue R-250. Densitometric analysis was
performed using ImageJ (Rasband, 1997–2005). Fluorometric quantification of Rhodamine labeled DHPE (λex/λem 560 nm/580 nm)
indicated that 87% ± 6.7% (SD) of the starting liposomes were
recovered in pellet fractions.
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Antibodies and immunoblotting
Antibodies against CPY (Rothblatt et al., 1989); Grh1p (Behnia et al.,
2007); Kar2p (Brodsky and Schekman, 1993); Och1p, Erv46p (Otte et
al., 2001); Sly1p (Flanagan and Barlowe, 2006); Sec22p (Liu and Barlowe, 2002); Bet1p, Bos1p (Sogaard et al., 1994); α1,6-mannose linkages, Sed5p (Cao et al., 1998); Sec63p (Feldheim et al., 1992); Uso1p,
Bet3p, Cog2p/Sec35p (Ballew et al., 2005); Erv25p (Belden and Barlowe, 1996); Gdi1p (Garrett et al., 1994); Sec13p (Salama et al., 1993);
Ypt1p (Rexach et al., 1994); Sec17p, Sec18p (Haas and Wickner,
1996); and Sec61p (Stirling et al., 1992) have been described. Polyclonal antibodies were raised against full-length untagged Bug1p as
follows: Bug1p was cloned into an Impact-CN protein expression
vector, purified according to the manufacturer’s specifications (New
England Biolabs), and used to immunize rabbits by standard procedures (Covance, Denver, PA). For Western blots, anti-Bug1p serum
was diluted 1:1,000. Monoclonal anti-5HIS was purchased from QIAGEN. Western blot analysis was performed with nitrocellulose membranes by using the SuperSignal West Pico chemiluminescent substrate (Pierce Chemical, Rockford, IL) and developed with a UVP
Bioimaging System (Upland, CA). Densitometric analysis of immunoblots was performed using ImageJ (Rasband, 1997–2005).

In vitro vesicle budding, tethering, and transport assays
Yeast semi-intact cell membranes and ER microsomes were prepared as described (Baker et al., 1988; Wuestehube and Schekman,
1992). Prior to assembling in vitro reactions, semi-intact cell membranes or microsomes were incubated with indicated inhibitors and/
or recombinant Sec18p for 20 min at 4ºC, or with Sac1WT for 30 min
at 12ºC as described in the text and figure legends. In vitro assays
to measure overall transport, vesicle budding, vesicle tethering,
two-stage fusion reactions, and SNARE cross-linking assays using
[35S]gpαf were performed as described (Barlowe, 1997; Cao et al.,
1998; Flanagan and Barlowe, 2006).
For vesicle purification on Nycodenz gradients, microsomes
containing [35S]gpαf were treated with 50 µM Sac1WT for 30 min at
12ºC and then used to generate COPII vesicles (Cao et al., 1998).
ER-derived vesicles were purified by flotation on Nycodenz density
gradients prepared in D2O to strip peripherally associated membrane proteins, and then floated vesicles were chased into washed
semi-intact cell membranes at 23ºC for 1 h (Barlowe, 1997).

Pulse-chase experiments
Wild type (SEY6210) and pik1–83 (AAY104) strains were grown at
26ºC in minimal medium to 0.4 OD600/ml (Beckman DU®-64 Spectrophotometer; Fullerton, CA), and then shifted to 37ºC for 25 min.
These cultures were washed in 37ºC-warm pulse-chase medium lacking cysteine, methionine, and sulfate, concentrated to 4 OD600/ml
(Audhya et al., 2000) and further incubated at 37ºC. In total, cultures
were shifted to 37ºC for 45 min prior to the pulse. Cultures were
pulsed for 7 min by the addition of EasyTag EXPRESS35S Protein
Labeling Mix (Perkin Elmer-Cetus, Waltham, MA) to a final concentration of ∼25 µCi/OD600. Cells were chased by the addition of
cysteine, methionine, and (NH4)2SO4 at a final concentration of
2.5 mM. Sample collection, lysis, and immunoprecipitations were
performed as described (Belden and Barlowe, 1996).

Microscopy
Samples at the indicated time points were concentrated to
14 OD600/ml in the presence of 0.008% methylene blue to identify
live versus dead cells (Teparic et al., 2004), and 3 ml was applied to
slides. Fluorescent and bright field images were acquired using a
microscope (model BX51; Olympus) equipped with a 100-W mercury
COPII vesicle fusion requires PI(4)P
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arc lamp, Plan Apochromat 60× objective (1.4 NA) and a Sensicam
QE CCD camera (Cooke Inc., Romulus, MI). The camera and microscope were controlled by the IP Lab system (Scanalytics, Sunnyvale,
CA). All images were processed in Openlab software (Improvision,
Lexington, MA).
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